Abstract
What is the mechanism behind acute bilineage leukemia (ie, 2 separate populations of myeloid and lymphoid blasts)? Why does the risk for therapy-related myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) last only 10 years, while the risk for therapy-related solid tumors can be lifelong
Full Text
Paper version not known (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call